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Biobased chemicals will inevitably be an important part of a sustainable organic chemical industry. 
Current efforts in biobased chemicals are largely driven by opportunistic chemical product targets 
requiring complete technology development from feedstock to final product for a specific 
molecule. To enhance the development of biobased chemicals, it is important to create strategies 
that can be more systematic and can leverage advancements across multiple final products. 
Discussed here is the concept of bioprivileged molecules, which are chemical intermediates that 
have the potential to be efficiently converted into a range of product molecules that can both 
directly replace existing petrochemicals and are novel molecules that impart enhanced 
performance properties in end-use applications.  
 
Background  
While chemicals derived from biomass have a long history, which actually predates 
petrochemicals, the growth of the organic chemical industry is intrinsically tied to technological 
development in the processing of fossil carbon (crude oil and natural gas).  The heart of the 
petrochemical industry is the thermal cracking technology platform that gives rise to C2-C4 
alkenes, benzene, toluene and xylenes (some of the aromatics are also recovered from other 
refinery streams). The molecules generated from the thermal cracking platform are subsequently 
converted to the broad array of chemicals that make up the prepondurance of the organic chemical 
industry. Although it was never called such at the time, the exploitation of thermal cracking-
derived molecules was essentially a highly successful application of the diversity-oriented 
synthesis (DOS) concept that has been proposed for small molecule drug discovery.1 The forward 
synthesis used in DOS was required since petrochemical end-use applications were developed 
around the available molecules rather than a priori knowledge of what would be a useful chemical 
structure.   
 
Against the background of the highly efficient and mature petrochemical enterprise, the desire to 
enhance the sustainability of the organic chemical industry has led to the start of the 21st century 
having the most concerted effort in biobased chemical development. As is common with a “new” 
technology area, the rapidly expanding number of researchers working in biobased chemicals led 
to a plethora of creative approaches for synthesizing specific organic chemicals from a range of 
biomass feedstocks including carbohydrates, triglycerides, lignin, protiens, etc. A common feature 
of most of these efforts were opportunistic biomass feedstock transformations that could result in 
a biomass-derived chemical for directly replacing an established petrochemical, e.g., the same 
chemical product made from biomass rather than fossil carbon. The retrosynthesis of a target 
chemical product from a biomass feedstock has the sustainability logic of substituting renewable 
carbon for nonrenewable carbon. However, this opportunistic retrosynthesis of target chemical 
products used for developing biobased chemicals clearly stands in stark contrast to the genesis and 
maturation of the petrochemical industry.  
 
The particularly pronounced differences are that the petrochemical industry is predicated on a 
platform feedstock conversion technology, thermal cracking, which is leveraged across a broad 
array of chemical products. The final chemical products are those with useful end-use properties 
that can also be efficiently synthesized from the intermediates generated by this platform 
technology. In contrast, biobased chemical synthesis approaches vary for different biomass 
feedstocks such that limited leveraging across multiple chemical products is realized. Also, 
biobased chemical product priorities are not defined by their end-use properties, but as target 
chemicals for direct replacement of existing petrochemicals. These characteristics of biobased 
chemical development lead to research vignettes rather than overarching strategic approaches and 
diminishes the potential for utilizing biomass to synthesis novel compounds yielding enhanced 
end-use performance properties. 
 
Several broader biobased chemical synthesis strategies have been proposed including a) platform 
intermediate compounds and b) a synthetic biology foundry, that seek to create technological 
approaches, which can be leveraged to impact the development of multiple chemical products. A 
series of two publications laid out promising biobased platform intermediate compounds from 
carbohydrate-based feedstocks in the form of a  “Top 10”  list followed by a “Top 10 + 4” list.2,3 
Key criteria for inclusion on the lists was the extent to which the biobased intermediate had 
received attention in the technical and patent literature and the potential to convert the intermediate 
to multiple chemical products with minimal subsequent steps. Important to note is the identified 
lists were not constrained by biological or chemical transformations from the starting 
carbohydrates, but were largely constrained by the chemical products accessible from the 
intermediates being direct replacements for existing petrochemicals. The platform concept also 
created the basis for examining the integration of biological and chemical transformations.4,5 The 
concept of a synthetic biology foundry has been proposed by a number of groups with a nice 
summary recently presented.6 The strength of this strategy is the systematic utilization of rapidly 
expanding tools to engineer biology for the synthesis of a desirable chemical through an 
increasingly rapid iterative design, build, test, learn (DBTL) cycle. The downside of the synthetic 
biology foundry is that unlike the original development of the organic chemical industry, it is 
instrinscally a retrosynthetic strategy.  
 
A purely retrosynthetic strategy for the development of biobased chemicals requires that the target 
molecule is known. Clearly in the case of directly replacing petrochemicals, these chemical targets 
are already established. However, an important attraction of biobased chemicals is not only their 
potential for sustainable organic chemicals but also their potential for providing novel chemical 
compounds that can lead to improved performance in end-use applications. The connection to end-
use application, i.e., polymers, specialty chemicals, preservatives, surfactants, etc., is vital since a 
novel compound has no inherent value without it. Working backwards from end-use properties to 
desirable chemical compounds necessitates understanding of structure-function relationships, e.g., 
knowing how a particular product property maps back to the chemical compound being used. In 
nearly all product development areas there has been significant effort directed towards developing 
structure-function relationships. While progress continues to be made due to increased 
computational capabilities, structure-function relationships that predict desirable novel chemical 
compounds remain elusive. 
 
As an illustration of the challenge in developing structure-function relationships, the case of 
preservatives (personal care and household products) can be considered, since there is significant 
market interest in green preservatives that can replace alkyl parabens and benzoic acid.7 The Green 
Chemistry and Commercial Conference (GC3) in conjunction with their industrial members 
established a list of technical criteria a novel preservative must meet to be considered for 
commercialization,8 which included: 
a. activity for a broad spectrum including gram-negative and gram-positive bacteria, mold, yeast, 
b. active for a pH range of 5 to 8, 
c. shelf life maintained in formulated product for 2 years and able to withstand multiple 
freeze/thaw cycles, 
d. effective use concentration of less than 2%,  
e. compatible with water and other hydrophilic ingredients, 
f. does not significantly affect product odor or color. 
In addition to these technical criteria, the preservative must also meet regulatory and health/safety 
criteria. Considering the technical criteria alone, it is difficult to imagine development of a robust 
structure-function relationship for preservatives that would allow for predicting a desirable novel 
chemical product for this application. 
 
Bioprivileged Molecule Concept  
There is no question that having structure-function predictive relationships would dramatically 
enhance the potential for finding valuable biobased chemicals. However, in the absence of having 
these robust relationships, biobased chemical synthesis strategies need to account for this issue. 
We recently proposed such a strategy that utilizes bioprivileged molecules, which are defined as 
“biology-derived chemical intermediates that can be efficiently converted to a diversity of 
chemical products including both novel molecules and drop-in replacements.”9 As noted in that 
manuscript there are several important components to this definition: 
1. It is an intermediate chemical species that can be generated from a biological feedstock, but 
cannot be effectively accessed from fossil carbon feedstocks.  
2. In addition to being a unique intermediate, it must still allow for efficient transformation to a 
number of valuable chemicals.  
3. Efficient transformation means minimal subsequent conversion steps that can be achieved with 
high carbon and hydrogen atom efficiency.  
4. It provides a pathway to a number of chemical products including both existing chemical 
products and novel chemical compounds, which can impart new end-use product properties.  
 
The bioprivileged molecules concept integrates and extends the platform and foundry strategies 
proposed previously. They are platform or intermediate molecules, but platform or intermediate 
molecules are not necessarily bioprivileged molecules (a comparison of attributes of platform 
versus bioprivileged molecules has been given).9 As in the definition, simply being a platform 
molecule does not address the ability for efficient transformation to an array of both novel and 
direct replacement molecules. The synthetic biology foundry provides a powerful approach for 
synthesizing bioprivileged molecules, which cannot be effectively accessed from petrochemical 
building blocks, but does not provide a framework by itself for determing what would be promising 
molecules to target for genetic engineering efforts.   
 
Any robust strategy for biobased chemical production must also consider its technological 
implementation. When introducing a new product there needs to be some advantage over the 
incumbent product. For biobased chemicals there are three possible advantages relative to 
petrochemicals that could drive their development including; a) price, b) sustainability, and c) 
product differentiation. Price alone is a difficult objective given the high efficiency, maturity and 
deployed capital infrastructure that exists for petrochemicals. Enhanced sustainability does have 
the potential to provide commercial pull through for organic chemicals made from biomass, but in 
the absence of price advantage this potential can only be realized by regulatory policies or 
customer willingness to pay extra for “green” chemicals. Product differentiation seems attractive 
as a novel chemical giving improved end-use product performance provides a compelling 
alternative to an existing petrochemical. The challenge with product differentiation is the organic 
chemical market already has a broad range of effective end-use applications that do not require 
improved performance. Therefore, markets open to product differentiation will commonly be 
niche-sized initially. If a chemical being developed only has niche potential, the economics of its 
development become problematic. However, if the niche chemical is produced from a 
bioprivileged molecule there is the potential to leverage the development costs and technological 
advances against additional chemical product opportunities.  
 
The idea of leverage from bioprivileged molecules can be demonstrated by considering the 
production of “sustainable” adipic acid. Given the significant environmental footprint of adipic 
acid production from petrochemical-derived cylcohexanol and cyclohexanone, adipic acid has 
received significant attention as a target molecule from biomass. Having a known target creates an 
opportunity to utilize a retrosynthetic strategy for developing an efficient reaction network for its 
production. Computational tools exist for finding such reaction networks in biological systems 
with one example being a program named Biological Network Integrated Computational Explorer 
(BNICE).10,11 This program utilizes an automated reaction network generation (NetGen)12 
approach to design synthethic pathways using reaction rules curated from biochemical reaction 
databases for identifying potential biological retrosynthetic pathways to a target molecule (see 
bottom of Figure 1). Once the possible biological pathways have been identified, the DBTL cycle 
can be utilized to develop an organism capable of synthesizing adipic acid. However, this approach 
would specifically develop a pathway for adipic acid only. Alternatively, the adoption of a 
bioprivileged molecule approach can be seen at the top of Figure 1, in which the biological target 
is muconic acid rather than adipic acid. Integrating the biological production of muconic acid with 
simple hydrogenation would lead to adipic acid.13 However, muconic acid has the desirable 
property that it can be leveraged as an intermediate to an array of chemical products with a few 
shown in the figure. 
 
More expansivley, muconic acid can serve as a bioprivileged molecule. Previous work has shown 
that muconic acid can be chemically converted into a number of additional large-volume 
petrochemicals including caprolactam, caprolactone, hexamethylene diamine, and terephthalic 
acid.14-16 However, muconic acid can also be converted to an array of novel molecules. We have 
recently shown that the NetGen computational approach can be used to explore DOS from a 
biological-derived intermediate molecule.17 By incorporating 16 common catalytic reaction 
families; hydrogenation, hydrogenolysis, hydrodeoxygenation, hydrolysis, dehydration, 
hydration, decarbonylation, decarboxylation, ketonization, esterification, keto-enol 
tautomerization, ring-opening/closing, aldol condensation, Diels-Alder, ketone amination, 
epoxidation, and selective oxidation, potential product molecules acessible from the conversion of 
a bioprivileged molecule could be identified. Shown in Figure 2 is the forward reaction network 
that in principle is accessable from muconic acid through at most two reaction steps. As noted in 
the figure, there are both known molecules as defined as those listed in PubChem (shown in the 
boxes) as well as novel compounds (not boxed).  While these are possible molecules from muconic 
acid, futher experimental work is needed to demonstrate the transformations. Importantly, the 
reaction network suggests molecules that could be explored if muconic acid was available as a 
bioprivileged molecule. 
 
One such interesting novel molecule is 3-hexenedioic acid (HDA) which has recently been shown 
to be generated from the efficient partial hydrogenation of muconic acid.18,19 Introduction of HDA 
as a monomer in place of adipic acid allows for the synthesis of nylons containing an unsaturated 
C-C bonds in the polymer chain. These bonds can be subsequently chemically modified for 
introducing novel nylon properties. The product differentiation made possible by HDA creates an 
initial technological and economic impetus for the development of muconic acid. However, the 
potential to convert efficiently muconic acid into a broad number of direct replacement and novel 
molecules further enhances and leverages the desirable development of muconic acid by creating 
a virtuous technological and economic cycle extending beyond a single chemical product. 
Importantly, the forward synthesis of HDA from muconic acid would not have been identified by 
simply targeting retrosynthesis of adipic acid.   
 
Bioprivileged Molecule Development  
We have previously discussed and shown “star” diagrams for other example bioprivileged 
molecules including triacetic acid lactone (TAL) and 5-hydroxymethylfurfural (HMF) that have 
received attention in the literature.9 An additional emerging bioprivileged molecule is coumalic 
acid, which can be produced by the dimerization of biological-derived maleic acid.20,21 Potentially 
accessible products from coumalic acid have recently been presented as a computational case 
study.17 While each of these chemical intermediates are demonstrations of bioprivileged 
molecules, the development of a bioprivileged molecule strategy can best be advanced if it can be 
utilized to create a more systematic approach for biobased chemical expansion.  
 
It is instructive to consider how the example bioprivileged molecules were identified. In the cases 
of TAL and HMF, their known synthetic accessability from carbohydrates led to researchers using 
DOS to find useful known and novel chemical products that could be produced from them. For 
example, the novel chemical product 2,5-furandicarboxylic acid (FDCA) appears to be the first 
commercialization target utilizing HMF as the intermediate. FDCA was not a retrosynthetic target 
but was instead identified as forward synthesis product from HMF. In contrast, the original interest 
in muconic acid and coumalic acid was due to their potential use as precursors to terephthalic acid, 
which was seen as a promising and desirable chemical for a green replacement, coupled with 
knowledge that there were biosynthetic pathways for their synthesis. With that identification as 
the starting point, subsequent DOS led to determination of their value as bioprivileged molecules. 
Given the success of those approaches in bioprivileged molecule identification, it is likely that 
other promising molecules could be found by adopting similar strategies. Unfortunately, the 
breadth of organic chemical options for either approach is daunting. In the former, biology 
synthesizes a vast number of metabolites, so it is difficult to imagine how to curate all of those 
molecules to those that are most promising. Targeting a final product is equally problematic given 
the large number of known organic chemical products. 
 
Our first approach for creating a more systematic strategy for bioprivileged molecule development 
was to consider computational forward synthesis from C6 oxygenates using automated reaction 
network generation.17 Constraining the candidate molecules to a preliminary list of just C6HxOy 
molecules created 29,252 possible molecules. Using down selection rules based on chemical 
features of known bioprivileged molecules, a set of 100 potential bioprivileged molecules were 
computationally determined. These 100 molecules need to be evaluated for the known and novel 
chemical products that can be efficiently synthesized with minimal subsequent transformaitons. In 
the case of novel chemical products, molecules that are similar in composition and structure to 
existing petrochemicals but with one additional functional group are particularly interesting. Also 
of interest, are bioprivileged molecules that can be used as a starting reactant for creating a library 
of compounds as was done in screening of a TAL-derived library for antimicrobial activity.9 After 
curating the possible products from the bioprivileged molecule candidates, the potential of 
synthesizing the bioprivileged molecule can be considered. 
 
While we are working on developing a systematic strategy for bioprivileged molecule 
identification, it remains an open question about how best to do so. Any such strategy would likely 
need to integrate computational capabilities for pathway design in biological systems, 
cheminformatics of chemical transformations and structure-function relationships in product 
applications. Given the complexity of performance parameters in end-use applications there will 
also envitability be a requirement for experimental screening of candidate molecules in product 
formulations. However, the utility of bioprivileged molecules makes the determination of such a 
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Figure 1: The lower figure demonstrates the retrosynthesis of just adipic acid whereas the upper 
figure demonstrates how bioprivileged molecule development for adipic acid can lead to 
additional molecules. 
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